These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26522415)

  • 1. [SUBLINGUAL IMMUNOTHERAPY].
    Gotoh M
    Arerugi; 2015 Aug; 64(8):1136-40. PubMed ID: 26522415
    [No Abstract]   [Full Text] [Related]  

  • 2. [YEAR IN REVIEW OF NASAL ALLERGY: SUBLINGUAL IMMUNOTHERAPY].
    Masuyama K
    Arerugi; 2015 Sep; 64(9):1210-4. PubMed ID: 26657909
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergy and immunology.
    Assa'ad A
    Pediatr Ann; 2014 Aug; 43(8):312. PubMed ID: 25102485
    [No Abstract]   [Full Text] [Related]  

  • 4. Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report.
    Li JT; Bernstein DI; Calderon MA; Casale TB; Cox L; Passalacqua G; Pfaar O; Papadopoulos NG
    J Allergy Clin Immunol; 2016 Feb; 137(2):369-76. PubMed ID: 26371843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future challenges of subcutaneous and sublingual allergy immunotherapy for allergists in the United States.
    Nelson HS
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):278-280. PubMed ID: 29409924
    [No Abstract]   [Full Text] [Related]  

  • 6. Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?
    Cox LS
    JAMA; 2017 Feb; 317(6):591-593. PubMed ID: 28196239
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of quality of life improvement in allergic rhinitis patients after sublingual immunotherapy.
    Katotomichelakis M; Riga M; Tripsianis G; Balatsouras D; Kourousis C; Danielides G; Giotakis E; Danielides V
    Ann Otol Rhinol Laryngol; 2015 Jun; 124(6):430-6. PubMed ID: 25539660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy in children: the recent experiences.
    Pleskovic N; Bartholow A; Skoner DP
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):582-90. PubMed ID: 25188717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained improvement of psoriatic lesions in the course of sublingual immunotherapy for airborne allergens: clinical evidence of cross-tolerance.
    Theodoropoulos DS; Morris MS; Morris DL
    Eur Rev Med Pharmacol Sci; 2015; 19(3):392-5. PubMed ID: 25720708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A web-based tool for improving adherence to sublingual immunotherapy.
    Tripodi S; Comberiati P; Di Rienzo Businco A
    Pediatr Allergy Immunol; 2014 Oct; 25(6):611-2. PubMed ID: 24965104
    [No Abstract]   [Full Text] [Related]  

  • 11. [SUBLINGUAL IMMUNOTHERAPY FOR MITE ALLERGIC RHINITIS].
    Okamoto Y
    Arerugi; 2016; 65(9):1187-1191. PubMed ID: 27885202
    [No Abstract]   [Full Text] [Related]  

  • 12. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
    Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
    J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cutting-edge of medicine; Sublingual immunotherapy for allergic rhinitis].
    Konno W; Haruna S
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):998-1005. PubMed ID: 26591351
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.
    Maloney J; Durham S; Skoner D; Dahl R; Bufe A; Bernstein D; Murphy K; Waserman S; Berman G; White M; Kaur A; Nolte H
    Allergy; 2015 Mar; 70(3):302-9. PubMed ID: 25495666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on house dust mite immunotherapy: are more studies needed?
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):542-8. PubMed ID: 25115684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sublingual immunotherapy].
    Goto M
    Arerugi; 2014 Feb; 63(1):65-6. PubMed ID: 24754098
    [No Abstract]   [Full Text] [Related]  

  • 17. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of dendritic cells on allergic rhinitis in sublingual therapy].
    Liu S; Ge R; Yu S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 28(14):1089-92. PubMed ID: 25330657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review.
    Didier A; Bons B
    Expert Opin Drug Saf; 2015 May; 14(5):777-88. PubMed ID: 25732009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy for allergic rhinitis].
    Yuta A
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Feb; 118(2):152-5. PubMed ID: 26506624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.